Subskrybuj

Dna moczanowa

15 min czytania
Strona główna › Protokoły › Metabolizm › Dna moczanowa

Dna moczanowa

Sebastian · Opublikowano: 17 maja 2026 • Zaktualizowano: 1 czerwca 2026

Cel protokołu

  • Przerwać napad i zmniejszyć ból/zapalnie.
  • Zwiększyć wydalanie kwasu moczowego i zmniejszyć jego pulę w organizmie (krystalizacja to końcówka procesu).
  • Ochronić nerki i zmniejszyć ryzyko kamicy.
  • Zmniejszyć ryzyko kolejnych napadów poprzez styl życia i dietę.
🔒

Pełen protokół tylko dla subskrybentów

Pełna lista suplementów, dawkowanie i kolejność wprowadzania — dostępne dla subskrybentów Standard i PRO.

Zobacz plany subskrypcji

Źródła naukowe

  1. Zhang W, Doherty M, Pascual E, Bardin T, Barskova V, Conaghan P, Gerster J, Jacobs J, Leeb B, Lioté F, McCarthy G, Netter P, Nuki G, Perez-Ruiz F, Pignone A, Pimentão J, Punzi L, Roddy E, Uhlig T, Zimmermann-Gòrska I; EULAR Standing Committee for International Clinical Studies Including Therapeutics. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006 Oct;65(10):1301-11. doi: 10.1136/ard.2006.055251. Epub 2006 May 17. PMID: 16707533; PMCID: PMC1798330.
  2. Sun SZ, Flickinger BD, Williamson-Hughes PS, Empie MW. Lack of association between dietary fructose and hyperuricemia risk in adults.NutrMetab. 2010;7(1):16.
  3. Schlesinger N, Norquist JM, Watson DJ. Serum Urate During Acute Gout. The Journal of Rheumatology. 2009;36(6): 1287-1289.
  4. Alvarez-Lario B, Macarrón-Vicente J. Is there anything good in uric acid? QJM. 2011
  5. Campion EW, Glynn RJ, DeLabry LO.Asymptomatic hyper- uricemia.Risk and consequences in the Normative Aging Study. Am J Med 1987; 82:421-6.
  6. Puig, J. G., de Miguel, E., Castillo, M. C., Rocha, A. L., Martínez, M. A., & Torres, R. J. (2008). Asymptomatic Hyperuricemia: Impact of Ultrasonography. Nucleosides, Nucleotides & Nucleic Acids, 27(6–7), 592–595. https://doi.org/10.1080/15257770802136040
  7. Michael Doherty, New insights into the epidemiology of gout, Rheumatology, Volume 48, Issue suppl_2, May 2009, Pages ii2–ii8
  8. Martinon, F., Pétrilli, V., Mayor, A. et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237–241 (2006). https://doi.org/10.1038/nature04516
  9. Eggebeen AT. Gout: an update. Am Fam Physician. 2007 Sep 15;76(6):801-8. PMID: 17910294.
  10. Bierer DW, Quebbemann AJ. Effect of L-dopa on renal handling of uric acid. J Pharmacol Exp Ther. 1982 Oct;223(1):55-9. PMID: 7120128.
  11. Scott JT. Drug-induced gout. Baillieres Clin Rheumatol. 1991 Apr;5(1):39-60.
  12. Singh JA, Reddy SG, Kundukulam J. Risk factors iew of the literature. CurrOpinRheumatol.2011:1.
  13. Caspi D, Lubart E, Graff E, Habot B, Yaron M, Segal R. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum. 2000 Jan;43(1):103-8. doi: 10.1002/1529-0131(200001)43:1<103::AID-ANR13>3.0.CO;2-C. PMID: 10643705.
  14. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004b;350(11):1093-1103.
  15. Choi HK, Curhan G. Beer, liquor, wine, and serum uric acic mination Survey. Arthritis Rheum 2004a; 51:1023 - 1029.
  16. Choi H, Atkinson K, Karlson E et al. Alcohol intake and risk of incident gout in men: a prospective study The Lancet, 363, 1277-1281
  17. Puig JG, Fox IH. Ethanol-induced activation of adenine nucleotide turnover.Evidence for a role of acetate. J Clin Invest 1984; 74: 936-41.
  18. T. GIBSON, A. V. RODGERS, H. A. SIMMONDS, P. TOSELAND, BEER DRINKING AND ITS EFFECT ON URIC ACID, British Journal of Rheumatology, Volume 23, Issue 3, August 1984, Pages 203–209, https://doi.org/10.1093/rheumatology/23.3.203
  19. Vandenberg MK, Moxley G, Breitbach SA, Roberts WN. Gout attacks in chronic alcoholics occur at lower serum urate levels than in nonalcoholics. J Rheumatol. 1994 Apr;21(4):700-4. PMID: 8035396.
  20. Larmon WA. Surgical management of tophaceous gout. Clin Orthop Relat Res. 1970;71:56-69. PMID: 4914841.
  21. Tc, Ford. “Surgical management of chronic tophaceous gout. A case report.” Journal of the American Podiatric Medical Association 82 (1992): 514-519.
  22. Feigelson P. The inhibition of xanthine oxidase in vitro by trace amounts of I-ascorbic acid. J BioChem 1952;197:843-50
  23. Choi HK, Gao X, Curhan G. Vitamin C Intake and the Risk of Gout in Men: A Prospective Study. Arch Intern Med. 2009;169(5):502–507. doi:10.1001/archinternmed.2008.606
  24. Koguchi T, Koguchi H, Nakajima H, Takano S, Yamamoto Y, Innami S, Maekawa A, Tadokoro T: Dietary fiber suppresses elevation of uric acid and urea nitrogen concentrations in serum of rats with renal dysfunction induced by dietary adenine. Int J VitamNutr Res 2004, 74(4):253-263.
  25. Kela U, Vijayvargiya R, Trivedi CP. Inhibitory effects of methyl-xanthines on the activity of xanthine oxidase. Life Sci 1980;27:2109-19.
  26. Choi, Hyon K. A prescription for lifestyle change in patients with hyperuricemia and gout. Current Opinion in Rheumatology 22(2):p 165-172, March 2010. | DOI: 10.1097/BOR.0b013e328335ef38
  27. Flynn, T.J., Cadzow, M., Dalbeth, N. et al. Positive association of tomato consumption with serum urate: support for tomato consumption as an anecdotal trigger of gout flares. BMC Musculoskelet Disord 16, 196 (2015). https://doi.org/10.1186/s12891-015-0661-8
Tematy w protokole
#dna-moczanowa#kwercetyna#omega-3#sylimaryna#witamina-c
← Wróć do bazy protokołów

Tagi